Observed Changes Post-treatment, patients often report a gradual lightening of skin tone, along with improved skin texture and a more even complexion
TZ: Software, Writing review & editing
TB-500 vs GHK-Cu: Special Populations Head-to-Head Comparison At a glance TB-500 source / active fragment of thymosin beta-4, a 43-amino-acid protein GHK-Cu source / tripeptide (Gly-His-Lys) complexed with copper(II) ion Primary TB-500 mechanism / actin sequestration, anti-inflammatory cytokine modulation, angiogenesis Primary GHK-Cu mechanism / TGF-beta and VEGF upregulation, collagen synthesis, antioxidant gene activation TB-500 typical dose / 2 to 5 mg subcutaneous injection 2x per week (loading), then 1 to 2 mg weekly GHK-Cu typical dose / 0.5 to 2 mg subcutaneous or topical (skin)
This results in higher levels of satiation, increased levels of fullness, and a reduced tendency to overeat
8 Peptide Stability & Storage GuidanceLyophilized vs reconstituted peptide handling: temperature, light and freeze-thaw considerations